In Stock & Ready to Ship

PANDAA qDx™ SARS-CoV-2 is a pathogen detection assay that is uniquely designed to provide accurate quantitative detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) specific RNA, the causative agent of the coronavirus disease 2019 (COVID-19).

For research use only (RUO). Not for use in diagnostic procedures.

Real-time PCR detection of COVID-19 Disease

  • Fast: Delivers accurate results from RNA in 1 hour
  • Scalable: Efficient workflow, 94 tests per run including controls
  • Plugs-in: Compatible with sample prep and qPCR platforms in most clinical labs
  • Supported: System includes templates, reagents, and on-site support for implementation

Click here for PANDAA qDx™ SARS-CoV-2 [EUA]

- +


PANDAA qDx™ SARS-CoV-2 is comprised of a single reaction mix containing reagents to amplify and detect targets within the SARS-CoV-2 genome. Two SARS-CoV-2 targets, located in the N gene and RdRp gene, respectively, are amplified by distinct PANDAA primer sets and detected by FAM™-labelled hydrolysis probes. An Internal Control (IC) target is amplified by PANDAA primers and reported using a VIC®-labelled hydrolysis probe.

Safety, legal, quality, & intended use remarks

  • This test has not been cleared or approved by the U.S. Food and Drug Administration (FDA)
  • This product is covered by one or more patents, trademarks and/or copyrights owned or controlled by Aldatu Biosciences, Inc.

Ordering (PANDAA qDx™ SARS-CoV-2 – RUO)

Catalog No. Quantity #Rxns Price
PQ.0012.Kit.96.RUO 1 to 9 96 reactions [30 µL]
94 samples + 2 controls
≥10 $1,645
PQ.0012.Kit.384.RUO 1 to 4 384 reactions [20 µL]
382 samples + 2 controls
≥5 $5,253